EANM共识文件:不明原因发热与炎症中[18F]FDG PET/CT的应用
欧洲核医学协会(EANM)感染与炎症委员会工作组基于PICOs进行系统文献检索,纳入2001至2023年发表的68篇文章(9篇系统综述、49篇一般成人原始论文、10篇特定人群原始论文),形成关于[18F]FDG PET/CT用于不明原因发热(FUO)和不明原因炎症(IUO)的循证推荐共识。共识指出[18F]FDG PET/CT在诊断路径中具有明确作用,总体诊断率或帮助性为50-60%,阳性扫描常通过直接指导治疗或后续诊断操作而有所贡献,阴性扫描可通过排除局灶性疾病和预测良好预后而同样重要;ICU患者、儿童和HIV患者等特定人群获得相似结果。
要点
- [18F]FDG PET/CT在FUO/IUO诊断路径中有明确作用,总体诊断率或帮助性为50-60%。
- 阳性扫描常通过直接指导治疗或后续诊断操作而有所贡献。
- 阴性扫描可通过排除局灶性疾病和预测良好预后而同样重要。
核心结论
- FUO和IUO仍是临床挑战,[18F]FDG PET/CT在诊断路径中具有明确作用,总体诊断率或帮助性为50-60%。
- 阳性扫描常通过直接指导治疗或后续诊断操作而有所贡献。
- 阴性扫描可通过排除局灶性疾病和预测良好预后而同样重要。
- ICU患者、儿童和HIV患者等特定人群获得相似结果。
研究设计与样本
- EANM感染与炎症委员会成立工作组,基于PICOs进行系统文献检索,以「FUO/IUO患者」为人群、「[18F]FDG-PET/CT」为干预,纳入包括扫描前特征、扫描方案、诊断率、对管理的影响、预后和成本效果等多个结局。
- 共纳入2001至2023年发表的68篇文章:9篇系统综述、49篇一般成人原始论文、10篇特定人群原始论文。
- 所有论文均被分析并纳入循证推荐。
主要发现
- [18F]FDG PET/CT在FUO/IUO患者中的总体诊断率或帮助性为50-60%。
- 阳性扫描常通过直接指导治疗或后续诊断操作而有所贡献,阴性扫描可通过排除局灶性疾病和预测良好预后而同样重要。
- 在ICU患者、儿童和HIV患者等特定人群中获得相似结果。
关键数值与推荐
- [18F]FDG PET/CT在FUO/IUO患者中的总体诊断率或帮助性为50-60%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients with fever and inflammation of unknown origin (FUO/IUO) are clinically challenging due to variable clinical presentations with nonspecific symptoms and many differential diagnoses. Positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) is increasingly used in FUO and IUO, but the optimal diagnostic strategy remains controversial. This consensus document aims to assist clinicians and nuclear medicine specialists in the appropriate use of [18F]FDG-PET/CT in FUO and IUO based on current evidence. METHODS: A working group created by the EANM infection and inflammation committee performed a systematic literature search based on PICOs with "patients with FUO/IUO" as population, "[18F]FDG-PET/CT" as intervention, and several outcomes including pre-scan characteristics, scan protocol, diagnostic yield, impact on management, prognosis, and cost-effectiveness. RESULTS: We included 68 articles published from 2001 to 2023: 9 systematic reviews, 49 original papers on general adult populations, and 10 original papers on specific populations. All papers were analysed and included in the evidence-based recommendations. CONCLUSION: FUO and IUO remains a clinical challenge and [18F]FDG PET/CT has a definite role in the diagnostic pathway with an overall diagnostic yield or helpfulness in 50-60% of patients. A positive scan is often contributory by directly guiding treatment or subsequent diagnostic procedure. However, a negative scan may be equally important by excluding focal disease and predicting a favorable prognosis. Similar results are obtained in specific populations such as ICU-patients, children and HIV-patients.
引用
- Hess S, Noriega-Álvarez E, Leccisotti L, et al. EANM consensus document on the use of [18F]FDG PET/CT in fever and inflammation of unknown origin. Eur J Nucl Med Mol Imaging. 2024. PMID: 38676736. doi:10.1007/s00259-024-06732-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。